| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.63M | 56.95M | 72.29M | 115.52M | 108.69M | 108.54M |
| Gross Profit | -6.66M | -17.25M | 841.00K | 26.03M | 22.83M | 16.51M |
| EBITDA | -17.36M | -30.93M | -9.78M | 17.81M | 14.68M | 6.25M |
| Net Income | -36.28M | -40.98M | -15.48M | 7.50M | 4.39M | 4.19M |
Balance Sheet | ||||||
| Total Assets | 176.92M | 173.97M | 226.05M | 205.85M | 222.86M | 209.57M |
| Cash, Cash Equivalents and Short-Term Investments | 8.50M | 10.94M | 31.16M | 11.68M | 15.14M | 12.69M |
| Total Debt | 29.10M | 31.28M | 39.83M | 31.97M | 21.05M | 8.62M |
| Total Liabilities | 72.51M | 68.22M | 77.56M | 72.93M | 87.87M | 76.36M |
| Stockholders Equity | 104.41M | 105.75M | 148.49M | 132.92M | 134.99M | 133.21M |
Cash Flow | ||||||
| Free Cash Flow | -12.48M | -8.85M | -15.36M | 738.00K | -274.00K | -10.96M |
| Operating Cash Flow | -8.56M | -3.14M | -6.09M | 4.27M | 6.28M | 22.00M |
| Investing Cash Flow | -9.34M | -11.13M | -15.03M | -5.96M | -15.67M | -42.91M |
| Financing Cash Flow | 7.06M | -3.87M | 38.44M | -1.32M | 12.38M | 16.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €771.45M | 4.85 | 6.32% | 5.81% | 16.92% | 146.69% | |
66 Neutral | HK$209.16M | 4.73 | 4.73% | ― | -20.52% | -68.47% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$303.34M | 1.10 | 19.13% | ― | -13.26% | 63.38% | |
49 Neutral | €1.06B | -2.36 | -15.58% | ― | -8.38% | -86.16% | |
45 Neutral | HK$153.00M | ― | -296.26% | ― | -49.77% | -1095.34% | |
40 Underperform | HK$198.36M | -0.52 | -30.61% | ― | -20.20% | -33.73% |
Sanergy Group Limited, a company incorporated in the Cayman Islands, has issued a supplemental announcement regarding its annual report for the year ended 31 December 2024. The announcement provides additional details about the company’s Share Option Scheme, specifically the exercise period for options, which can be exercised at any time within a period determined by the Board, not exceeding 10 years from the grant date. This supplementary information does not affect other details in the annual report.